Contraception
Volume 81, Issue 3 , Pages 197-201, March 2010

Sino-implant (II) — a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials☆☆☆

  • Markus J. Steiner

      Affiliations

    • Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 544 7040x11346; fax: +1 919 544 7261.
    • ,
  • Laureen M. Lopez

      Affiliations

    • Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA
    • ,
  • David A. Grimes

      Affiliations

    • Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA
    • ,
  • Linan Cheng

      Affiliations

    • Centre for Clinical Research and Training, Shanghai Institute of Planned Parenthood Research (SIPPR), Shanghai 200032, PR China
    • ,
  • Jim Shelton

      Affiliations

    • Bureau for Global Health, United States Agency for International Development, Washington, DC, USA
    • ,
  • James Trussell

      Affiliations

    • Office of Population Research, Princeton University, Princeton, NJ 08544, USA
    • The Hull York Medical School, University of Hull, HU6 7RX Hull, UK
    • ,
  • Timothy M.M. Farley

      Affiliations

    • Department of Reproductive Health and Research, World Health Organization, CH-12211 Geneva 27, Switzerland
    • ,
  • Laneta Dorflinger

      Affiliations

    • Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA

Received 20 August 2009; received in revised form 30 October 2009; accepted 30 October 2009. published online 07 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ FHI is the recipient of grant funding to provide quality testing of Sino-Implant (II) independent of Shanghai Dahua Pharmaceuticals' own QA/QC tests [1], to assist Dahua in identifying distribution partners and to provide technical assistance to distributors in the registration and introduction of the product. Distributors of the product provide a preferential price to the public sector. Dr. Steiner is part of a consulting firm facilitating regulatory approval and product testing of other reproductive health products. Dr. Grimes has consulted with Bayer Healthcare Pharmaceuticals and Schering-Plough, two manufacturers of contraceptive implants.

☆☆ Support for this research was provided by the Bill & Melinda Gates Foundation. The views expressed in this publication do not necessarily reflect those of FHI, the World Health Organization or the funding agency.

PII: S0010-7824(09)00484-3

doi:10.1016/j.contraception.2009.10.013

Contraception
Volume 81, Issue 3 , Pages 197-201, March 2010

Article Tools